|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.43 CNY | -0.44% |
|
-4.00% | +14.79% |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 05-25 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 5.44B 800M 699M 642M 599M 1.14B 76.18B 1.15B 7.73B 3B 37.37B 3B 2.94B 129B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.78B 852M 744M 683M 637M 1.21B 81.07B 1.23B 8.23B 3.19B 39.76B 3.2B 3.13B 137B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.74% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -0.44% | ||
| 1 week | -4.00% | ||
| Current month | +6.50% | ||
| 1 month | -18.26% | ||
| 3 months | +18.33% | ||
| 6 months | +14.79% | ||
| Current year | +14.79% |
| 1 week | 12.1 |  | 13.9 |
| 1 month | 12.1 | | 17.23 |
| Current year | 10.49 | | 17.46 |
| 1 year | 10.49 | | 17.46 |
| 3 years | 10.49 | | 20.34 |
| 5 years | 10.49 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 26/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 31/08/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 31/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 28/02/2018 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 28/02/2018 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 27/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/09/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 01/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 04/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | -4.00% | +13.33% | -21.28% | 800M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +2.93% | -1.94% | +26.41% | +20.22% | 339B | |
| -0.83% | +0.82% | +41.47% | +39.16% | 301B | |
| -0.31% | +1.12% | +31.92% | +44.23% | 292B | |
| -1.53% | +2.94% | -25.26% | -39.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.22% | +4.21% | +29.34% | +49.32% | 370.05B | |
| Weighted average by Cap. | +1.30% | +5.21% | +41.72% | +81.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 316M 276M 253M 236M 448M 30.05B 455M 3.05B 1.18B 14.74B 1.19B 1.16B 50.79B | 1.7B 251M 219M 201M 188M 356M 23.87B 362M 2.42B 939M 11.71B 941M 921M 40.34B |
| Net income | 274M 40.34M 35.25M 32.37M 30.19M 57.23M 3.84B 58.19M 390M 151M 1.88B 151M 148M 6.49B | 46.25M 6.81M 5.95M 5.46M 5.1M 9.66M 648M 9.82M 65.79M 25.5M 318M 25.57M 25.01M 1.1B |
| Net Debt | 108M 15.85M 13.85M 12.72M 11.86M 22.48M 1.51B 22.86M 153M 59.35M 740M 59.52M 58.22M 2.55B | 349M 51.34M 44.86M 41.19M 38.41M 72.82M 4.89B 74.05M 496M 192M 2.4B 193M 189M 8.26B |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | CN¥13.43 | -0.44% | 14,537,700 |
| 01/07/26 | CN¥13.49 | +6.98% | 14,698,200 |
| 30/06/26 | CN¥12.61 | -1.87% | 13,066,300 |
| 29/06/26 | CN¥12.85 | -2.95% | 21,777,900 |
| 26/06/26 | CN¥13.24 | -5.36% | 12,592,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
